We only have this paper's title and publication details.
Read it at the sourceEvaluates silymarin's ability to reduce oxidative stress and renal damage in mice, indicating its potential for therapeutic use.
No takes yet. Share an insight, caveat, or question.
Başer et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: